Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity - Test2 - elhamkhani - TriplyDB

Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity

Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity

http://www.wikidata.org/entity/Q35553325

about

Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases Immunological characteristics and T-cell receptor clonal diversity in children with systemic juvenile idiopathic arthritis undergoing T-cell-depleted autologous stem cell transplantation.An optical imaging method to monitor stem cell migration in a model of immune-mediated arthritis.Stem cells in clinical practice: applications and warnings.In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional label Cell therapy for autoimmune diseases Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines.Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment.Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States.Macrophage activation syndrome and other systemic inflammatory conditions after BMT.Juvenile idiopathic arthritis: current and future treatment options.Haemopoietic stem cell transplantation--an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology.The use of stem cells for the treatment of autoimmune diseases.Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives.Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis Immune re-education following autologous hematopoietic stem cell transplantation.Regulatory T cells in autologous stem cell transplantation for autoimmune disease.Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go.Regulatory T cells as therapeutic targets in rheumatoid arthritis.Treating arthritis by immunomodulation: is there a role for regulatory T cells?Induction of immune tolerance in the treatment of rheumatoid arthritis.Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases.Hematopoietic stem cell transplantation for curing children with severe autoimmune diseases: is this a valid option?An update on stem cell transplantation in autoimmune rheumatologic disorders.Could mesenchymal stromal cells have a role in childhood autoimmune diseases?T regulatory cells in childhood arthritis--novel insights.Hematopoietic stem cell transplantation in children with autoimmune connective tissue diseases.Stem cell therapy in autoimmune rheumatic diseases: a comprehensive review.Novel treatment options for juvenile idiopathic arthritis.Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.New frontiers in the treatment of systemic juvenile idiopathic arthritis.The use of hematopoietic stem cells in autoimmune diseases.Treatment of refractory autoimmune diseases with autologous stem cell transplantation: focus on juvenile idiopathic arthritis.Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice.Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis.Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis Stem Cell Applications for Treatment of Cancer and Autoimmune Diseases: Its Promises, Obstacles, and Future Perspectives

P2860

Q30795448-0C301910-4FBA-4113-9D1F-A4FB25B41799 Q33559048-86AB4CFB-9822-44BE-B29C-57FF89211929 Q33924632-2643D605-7A6C-4E9D-A01A-A69A3792DD38 Q34552765-0253C527-F5E1-48DF-B505-40F88437CFFE Q34698260-D77B3871-E341-48E7-8CD0-FFEBC6752479 Q35868954-47748B6B-432D-4790-8186-C75E8F4587E3 Q36020897-48558EEE-20C5-4247-B6EF-56A5DCF800F5 Q36138154-72A59CE7-74BE-4302-9E9D-FE417374377E Q36204110-D2656928-5188-448A-8F32-CB853E4D7BDD Q36252940-4EC45692-A574-49E8-907C-63C478F42780 Q36406434-5AA56CDE-AAAC-454E-9EB2-4DD7F69D2882 Q36407354-0E21E5A9-3385-4A13-8E8D-FA6DA7771F58 Q36844901-A46C135A-775B-4E3E-93AB-066729100311 Q36916687-1FE0BFF2-1212-46C2-A4B8-8EA8DF66D832 Q37188496-777F8DC3-F53A-4CDE-A0B5-2D7D93F05BF5 Q37207120-53C1ED00-EC53-4CDA-BC75-C7B239871C7C Q37311055-2D7B6526-C232-4D90-A028-470245E17ED5 Q37311088-1D1709CB-F379-4D49-844E-353E0B3EAB0F Q37549888-2F6E67CB-90A5-40BA-8355-1F053AD35B7F Q37607071-B659DC20-925F-49DB-94B9-82F25F9AC947 Q37750140-DBE43513-B63E-48DD-90C8-BCB59EE0D3DB Q37862081-8E311722-D1E3-41E9-9349-508FAB398FAF Q37995011-C7D3A9E0-3DA2-4DA8-89BF-41A418DDFA31 Q38004048-23764D68-7A9B-4C13-9C5C-AEC19252AE12 Q38041499-5582A330-E6B8-4706-AEA6-ABD4AA425CAC Q38134131-F0554F6A-E3C5-4019-93A5-B10A7895D8F1 Q38167815-B4600CCB-70C2-4168-B5CD-9242FE627FA9 Q38194074-6D8696F0-9CE7-4F91-A4C2-19C2F54087CE Q38242079-8966794A-6FAE-4B7B-B789-3A16FE9AEA7D Q38570721-1F5DF956-4A2A-4987-BB4A-ED0FA9FDB3CE Q38648790-93FACF81-BB93-46BD-8770-DEB64E1A81A5 Q39424746-596128AC-31ED-429F-B5D8-9F2068ACC533 Q39777434-E3F4E3EE-5B2D-43E8-AA7D-ADE271A900E0 Q40432675-BB553AA6-4362-4944-9BD0-A90F6BBCC67A Q42868832-4DFA3819-8B43-43ED-ACF8-D0FC519777FC Q43173646-294ACF84-75CD-478A-BB79-083C86727F65 Q57094411-AB1A870F-9B0D-46EC-8BFF-25502945AE85 Q57826825-5A4B380E-A08F-47AD-A325-7D16B6B7F68D

P2860

Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity

http://www.wikidata.org/entity/Q35553325

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Autologous stem cell transplan ...... d transplant related morbidity

@ast

Autologous stem cell transplan ...... d transplant related morbidity

@en

type

label

Autologous stem cell transplan ...... d transplant related morbidity

@ast

Autologous stem cell transplan ...... d transplant related morbidity

@en

prefLabel

Autologous stem cell transplan ...... d transplant related morbidity

@ast

Autologous stem cell transplan ...... d transplant related morbidity

@en

P1433

Q35553325-5201AD34-2CB6-41EE-841A-6219639B3CF8

P1476

Q35553325-CA096BC8-DE98-4BE0-873B-48A1C0978AB9

P2093

Q35553325-2236DEE8-5A49-4FD8-81FE-2136DA28C66A

Q35553325-3CA579B3-2313-462D-92BC-F883B32A68F3

Q35553325-4D82941C-FA8C-484F-8DDB-D8EF87877680

Q35553325-664B9C64-9A89-4E56-AEE2-37DBE6185111

Q35553325-67C199E5-D6F6-467F-A23A-23BC84AD2139

Q35553325-725B5922-4125-4995-8C1C-2E337C4C06A0

Q35553325-74291210-4C2D-4C98-ABEA-A3E4A70CA449

Q35553325-9066EDDC-2D7A-447E-86A6-27C66E75BEC8

Q35553325-A1F50598-80BE-4FAA-91F7-A54ED745D7F5

Q35553325-AFE731FF-723D-4919-AAF4-33A917AF3FED

P2860

Q35553325-046553C2-E47F-40B8-8541-2DC35BE4B170

Q35553325-084FC791-C6DD-457F-A6AD-01172DB9F7BD

Q35553325-0D8F0ECF-3E83-48DC-82D2-A019904294DC

Q35553325-0DAC5AF1-3447-44AB-8AF9-EED3BC734CB2

Q35553325-181D59CB-0F25-4097-8B7D-401651897F5E

Q35553325-1DF8AB47-6AFF-43CC-B675-0EDEEE95C380

Q35553325-37A8C4BF-2ECB-43A1-A178-14760AC87309

Q35553325-3BE7D875-700C-4A39-9FD0-D58006E723AE

Q35553325-49A32E4B-264B-4C7B-BB42-DDD6ADE3C788

Q35553325-4B955BEE-5B0B-4673-ADCA-6340CCF31D38

P304

Q35553325-2A4A191C-A797-4FC0-8F13-A06B8EA0E654

P31

Q35553325-B53E4403-5513-4434-9BCC-C23BA300CB04

P356

Q35553325-F47ECD71-9F78-43EF-8ABE-1D643F3E5CAA

P407

Q35553325-1E0DC5E9-D837-4A02-98F1-8F89DA191A5E

P433

Q35553325-F299EE9F-0216-4248-895B-23D4DF3A6823

P478

Q35553325-0D075A92-4BBE-43C5-89FB-592189CBF530

P50

Q35553325-00CA295B-5B5A-46A3-9C7C-326BF5AD714F

Q35553325-B1CCFA75-3F5F-4803-951C-92CA2E495A5D

P577

Q35553325-D2A3558C-6A35-447A-982D-BF3B91A0C5C2

P5875

Q35553325-A1A0150B-ED9C-4D72-B1E6-4539F62C3E27

P698

Q35553325-1589BD35-D2FB-4259-8A01-EF8FD20659A9

P921

Q35553325-E3A1AA83-8047-47BD-8B68-755E73B0066D

P932

Q35553325-01619315-D0B6-4B87-B77E-B365087193EE

P356

ARD.2003.017798

P1433

Annals of the Rheumatic Diseases

P1476

Autologous stem cell transplan ...... d transplant related morbidity

@en

P2093

Abinun M

http://www.w3.org/2001/XMLSchema#string

Brinkman DM

http://www.w3.org/2001/XMLSchema#string

De Kleer IM

http://www.w3.org/2001/XMLSchema#string

Fasth A

http://www.w3.org/2001/XMLSchema#string

Ferster A

http://www.w3.org/2001/XMLSchema#string

Foster HE

http://www.w3.org/2001/XMLSchema#string

Horneff G

http://www.w3.org/2001/XMLSchema#string

Kuis W

http://www.w3.org/2001/XMLSchema#string

Oppermann J

http://www.w3.org/2001/XMLSchema#string

Prieur AM

http://www.w3.org/2001/XMLSchema#string

P2860

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study.

Hematopoietic stem cell transplantation for autoimmune disorders.

Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Aga

High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis.

Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease.

Autologous bone marrow transplantation versus alternative drugs in pediatric rheumatic diseases.

Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis.

Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group

Juvenile rheumatoid arthritis: outcome and treatment for the 1990s.

P304

1318-1326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2003.017798

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Pierre Quartier

Lucy R Wedderburn

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8353751

http://www.w3.org/2001/XMLSchema#string

P698

15361393

http://www.w3.org/2001/XMLSchema#string

P921

juvenile rheumatoid arthritis

P932

1754760

http://www.w3.org/2001/XMLSchema#string